XML 24 R6.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:    
Net loss $ (28,962,000) $ (19,445,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation of property and equipment 39,000 38,000
Redeemable warrants valuation adjustment (35,000)
Gain on sale of fixed assets (18,000)
Abandonment and expiration of patents and trademark rights 14,000
Amortization of patent and trademark rights 199,000 218,000
Non-cash lease expense 287,000 (680,000)
Loss from sale of income tax operating losses 197,000
Equity-based compensation 243,000 954,000
Loss (gain) on sale of marketable investments (200,000) 1,679,000
Change in assets and liabilities:    
Funds receivable from New Jersey operating loss sales 492,000 (35,000)
Prepaid expenses and other current assets 153,000 (151,000)
Lease liability (274,000) 688,000
Other assets (486,000) (83,000)
Accounts payable 6,066,000 179,000
Accrued expenses 1,180,000 368,000
Net cash used in operating activities (21,267,000) (16,108,000)
Cash flows from investing activities:    
Proceeds from sale of marketable investments 1,299,000 10,083,000
Purchase of marketable investments (1,593,000) (2,724,000)
Purchase of property and equipment (86,000)
Proceeds from sale of property and equipment 47,000 3,900,000
Purchase of patent and trademark rights (585,000) (185,000)
Net cash (used in) provided by investing activities (832,000) 10,988,000
Cash flows from financing activities:    
Proceeds from sale of stock, net of issuance costs 485,000 80,000
Net cash provided by financing activities 485,000 80,000
Net decrease in cash and cash equivalents (21,614,000) (5,040,000)
Cash and cash equivalents at beginning of year 27,053,000 32,093,000
Cash and cash equivalents at end of year 5,439,000 27,053,000
Supplemental disclosures of non-cash investing and financing cash flow information:    
Unrealized gain (loss) on marketable investments 376,000 (928,000)
Conversion of Series B preferred 7,000 19,000
Operating lease liability arising from obtaining right of use asset $ 73,000 $ 736,000